Infection Risk Prediction After Liver Transplant
Treatments studied
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study develops a tool to predict which liver transplant patients might develop infections after surgery. By identifying high-risk patients early, doctors could provide extra monitoring or preventive care to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are waiting for or have just received a liver transplant
- Your liver disease is caused by cirrhosis, hepatitis, or acute liver failure
- You are 18 years or older and able to provide your own consent
- You are enrolled in the French social security system
- You have not taken immunosuppressive medications before transplant (except low-dose steroids for liver inflammation)
- You are not receiving a transplant of multiple organs at once
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what germs cause infections in people who have had a liver transplant. It aims to help doctors better prevent and treat infections after transplant.
This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study looks at how blood sugar levels during surgery affect the risk of infections after a liver transplant. It aims to see if better blood sugar control can reduce complications.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.